CytoDyn Inc (CYDY)
0.155
0.00 (0.00%)
USD |
OTCM |
Apr 19, 15:59
CytoDyn Cash from Operations (TTM): -12.74M for Feb. 29, 2024
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
February 29, 2024 | -12.74M |
November 30, 2023 | -16.63M |
August 31, 2023 | -18.53M |
May 31, 2023 | -25.11M |
February 28, 2023 | -27.74M |
November 30, 2022 | -32.57M |
August 31, 2022 | -57.06M |
May 31, 2022 | -77.72M |
February 28, 2022 | -104.48M |
November 30, 2021 | -117.09M |
August 31, 2021 | -108.37M |
May 31, 2021 | -117.57M |
February 28, 2021 | -114.08M |
November 30, 2020 | -107.95M |
August 31, 2020 | -94.56M |
May 31, 2020 | -68.80M |
February 29, 2020 | -49.00M |
November 30, 2019 | -46.25M |
August 31, 2019 | -56.69M |
May 31, 2019 | -50.47M |
February 28, 2019 | -47.93M |
November 30, 2018 | -43.20M |
August 31, 2018 | -31.87M |
May 31, 2018 | -29.90M |
February 28, 2018 | -30.09M |
Date | Value |
---|---|
November 30, 2017 | -28.85M |
August 31, 2017 | -27.47M |
May 31, 2017 | -26.73M |
February 28, 2017 | -24.80M |
November 30, 2016 | -27.07M |
August 31, 2016 | -25.82M |
May 31, 2016 | -24.81M |
February 29, 2016 | -23.82M |
November 30, 2015 | -15.26M |
August 31, 2015 | -14.69M |
May 31, 2015 | -12.02M |
February 28, 2015 | -9.517M |
November 30, 2014 | -9.759M |
August 31, 2014 | -9.156M |
May 31, 2014 | -7.387M |
February 28, 2014 | -6.633M |
November 30, 2013 | -5.123M |
August 31, 2013 | -3.787M |
May 31, 2013 | -3.393M |
February 28, 2013 | -3.902M |
November 30, 2012 | -4.261M |
August 31, 2012 | -4.257M |
May 31, 2012 | -4.391M |
February 29, 2012 | -3.359M |
November 30, 2011 | -2.323M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-117.57M
Minimum
May 2021
-12.74M
Maximum
Feb 2024
-65.17M
Average
-56.87M
Median
Cash from Operations (TTM) Benchmarks
NovaBay Pharmaceuticals Inc | -4.131M |
Palatin Technologies Inc | -26.54M |
iBio Inc | -18.89M |
Theriva Biologics Inc | -19.00M |
Ampio Pharmaceuticals Inc | -8.564M |